Diplomatic Relations / Business Partnership / Company Expansion / /
Facility
University College London / University of Toronto / /
IndustryTerm
bioresorbable hydrogel technology / regenerative medicine products / stem cell banking / cell-based products / biomaterials-based products / Online Publishing Awards / business to business / technology development / manufacturing facilities / promising technologies / translational technology platforms / technology commercialization / regenerative medicine technologies / substantial network / therapeutic applications / foundational technologies / /
MedicalCondition
costly diseases / diseases / /
MedicalTreatment
cell therapy / /
Organization
University College London / McGill University’s Centre of Genomics and Policy / Pfizer-CCRM Innovation Fund / UK government / Strategic Advisory Board / Centre of Excellence for Commercialization and Research / Regenerative Medicine Coalition / Founders Advisory Board / Ethics Unit / McEwen Centre for Regenerative Medicine / Commercialization Review Committee / Government of Canada / Centre of Excellence / Ministry of Science and Technology / Centre for Commercialization / CC CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE / SickKids’ Transplant and Regenerative Medicine Centre / Ontario’s Ministry of Economic Development and Innovation / University of Toronto / MEDI’s Ontario China Research and Innovation Fund / Innovation Fund / /
Person
Andras Nagy / Gordon Keller / Centre / Chris Mason / Stanford Zandstra Rudnicki Sefton / Peter Zandstra / Derek van der Kooy / Thomas Waddell / Molly Shoichet / Ellis Keller Rossant Nagy Shoichet / /
Position
Chair / Board of Directors / ADVISORS / Chief Scientific Officer / leader / Professor / President and CEO / EXECUTIVE / Professor of Regenerative Medicine / /
ProvinceOrState
Ontario / /
PublishedMedium
Toronto Life / /
Technology
Genomics / transplantation / stem cells / manufacturing facilities Company incubation Contract research services Technology / versatile / bioresorbable hydrogel technology / drug screening / Out-licensing High value technologies / biomaterials / regenerative medicine technologies / RM technologies / REGENERATIVE MEDICINE / /